North America Anti-Snoring Devices Market Research Report, 2028

North America Anti-Snoring Devices Market Research Report, 2028

Actual Market Research 31-03-2023 93 Pages Figures : 12 Tables : 15 Region : North America Category : Lifescience Medical Devices

1. Koninklijke Philips

2. ResMed

3. GlaxoSmithKline plc.

4. LivaNova PLC

5. Fisher & Paykel Healthcare Corporation Limited


Consumers in North America are looking for cost-effective +solutions to manage their snoring and sleep disorders as healthcare costs continue to rise. Anti-snoring devices are frequently less expensive than prescription medications or surgical treatments, making them an appealing option for consumers looking to control snoring and improve their sleep. Furthermore, there has been a significant increase in the development of new and innovative anti-snoring devices in recent years. These devices are designed to be more comfortable, effective, and convenient than traditional devices, making them more appealing to consumers. Moreover, home sleep testing (HST) is gaining popularity as a convenient and cost-effective method of diagnosing sleep disorders. The demand for anti-snoring devices is expected to rise as more people undergo HST and are diagnosed with sleep apnea and snoring. In addition, as consumers increasingly seek non-invasive and drug-free treatment options, anti-snoring devices are becoming a popular choice. These devices offer a non-invasive way to alleviate snoring and improve sleep quality without the need for medication or surgery. According to the research report, "North America Anti Snoring Device Market Research Report, 2028", published by Actual Market Research, the North America Anti Snoring Device market was valued at more than USD 489.20 Million in 2022. Snoring can lead to a range of health risks, including high blood pressure, heart disease, and stroke. As awareness about these risks increases, more people are seeking solutions to reduce or eliminate their snoring, driving demand for anti-snoring devices. Furthermore, as the population in North America ages, there is a higher likelihood of developing snoring and sleep disorders. This demographic trend is driving demand for anti-snoring devices. Moreover, the anti-snoring device market is benefiting from advances in technology, such as the development of wearable devices and smart sensors that can monitor sleep and snoring patterns. These devices are helping to improve the accuracy and effectiveness of anti-snoring devices, driving demand. Furthermore, Consumers are looking for anti-snoring devices that are tailored to their specific needs and preferences. This has led to the development of customizable devices, such as MADs that can be adjusted for a more personalized fit, driving demand for these types of products. Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the North American market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy. The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in North America, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices. According to the report, the North American market is segmented into three major countries, including the United States, Canada, and Mexico. Among these, the United States leads the North America Anti-Snoring Device market. The demand for non-invasive snoring treatments, including anti-snoring devices, is growing in the USA due to the high cost and potential side effects of surgical treatments. Moreover, among the various types of anti-snoring devices, mandibular advancement devices (MADs) are the most commonly used in the USA. MADs work by moving the lower jaw forward to open up the airway and reduce snoring. Furthermore, the market for wearable anti-snoring devices is growing rapidly in the USA. These devices, such as smartwatches and fitness trackers, are equipped with sensors that can detect snoring and provide feedback to users. In addition, some insurance plans in the USA cover the cost of anti-snoring devices for patients diagnosed with sleep apnea. However, coverage may vary depending on the insurance provider and the specific device prescribed. Anti-snoring products have a long history in North America, with some products dating back several decades. Anti-snoring products were initially designed to provide relief from snoring and related sleep disturbances through simple and non-invasive means. Furthermore, the nasal strip, which was introduced in the 1990s, was one of the first anti-snoring products. These strips are applied to the outside of the nose to help open the nasal passages and improve sleep breathing. The "snore ball," a small object that is placed in a pocket on the back of a person's pyjamas to help prevent them from sleeping on their back, which is a common cause of snoring, was another early anti-snoring product. In North America, there has been a rise in the development and availability of high-tech solutions for anti-snoring products. These products typically use advanced technology and sensors to detect and analyze snoring patterns and provide feedback or interventions to reduce snoring and improve sleep quality. A high-tech anti-snoring product is the "smart" anti-snoring pillow. This pillow is designed to detect snoring through embedded sensors and automatically adjust its position to help reduce snoring. It can also provide feedback to users through a connected app that tracks their sleep patterns and provides suggestions for improving sleep quality. Furthermore, a high-tech anti-snoring product is the "snore-tracking" wearable device. This device is worn on the wrist like a watch and uses sensors to monitor snoring patterns throughout the night. It can also track other sleep-related metrics, such as sleep duration and quality, and provide personalized recommendations for improving sleep habits. Moreover, there are also various smartphone apps available that claim to help reduce snoring by playing specific sound frequencies or tracking sleep patterns. Some of these apps use artificial intelligence (AI) algorithms to analyze snoring patterns and provide personalized recommendations for reducing snoring. ResMed, a leading manufacturer of sleep apnea devices, and Verily, a subsidiary of Alphabet Inc., formed a joint venture called JAZZ to develop personalized sleep apnea treatments using advanced data analytics and machine learning. Furthermore, Philips, a global healthcare technology company, partnered with BioIntelliSense, a medical wearables company, to develop a remote monitoring solution for at-risk patients with chronic conditions such as sleep apnea. Moreover, Itamar Medical, a medical device company specializing in sleep apnea and other respiratory disorders, entered into a distribution agreement with ZOLL Medical, a manufacturer of medical devices and related software solutions. Moreover, SleepScore Labs, a sleep technology company, partnered with Sleep Number, a leading bedding and mattress manufacturer, to develop and market a smart bed that uses advanced sensors and machine learning algorithms to optimize sleep quality. In addition, SnoreLab, a mobile app that helps users track and analyze their snoring patterns, partnered with SnoreRx, a manufacturer of custom-fit anti-snoring devices, to provide users with personalized treatment recommendations based on their snoring data. Anti-snoring device camps are becoming more popular in North America as more people seek solutions to their snoring problems. Many anti-snoring device camps in North America are located in scenic outdoor settings, such as national parks or lakeside campsites. Furthermore, anti-snoring device camps in North America often include education and counseling on healthy sleep habits, stress management, and other related topics. Moreover, there are several clinics and medical centers in North America that offer sleep studies, diagnosis, and treatment for snoring and sleep apnea. Some of the popular clinics and medical centers are the Mayo Clinic Sleep Disorders Center, Stanford Sleep Medicine Center, Mount Sinai Sleep Center, University of Alberta Sleep Clinic, Vancouver Coastal Health Sleep Disorders Program, Ottawa Sleep Clinic, Sleep Health Institute of Massachusetts, The Snoring Center, Center for Sleep Medicine, and Cleveland Clinic Sleep Disorders Center. Start-ups: Hüpnos is a startup that has developed a smart sleep mask that uses sensors to monitor breathing patterns and adjust air pressure to prevent snoring. The mask also has an accompanying app that provides personalized coaching and tracks sleep metrics. Furthermore, Snore Circle is a startup that has developed a small, wearable anti-snoring device that uses micro-sound technology to detect snoring and emits micro-vibrations to stimulate the throat muscles and prevent snoring. The device can be worn comfortably on the wrist or placed under the pillow. Moreover, Airing is a startup that has developed a disposable micro-CPAP device that fits inside the nostrils and delivers positive airway pressure to prevent snoring. The device is designed to be small, comfortable, and easy to use. Furthermore, Silent Partner Technologies is a startup that has developed a wearable anti-snoring device that uses patented Active Noise Cancellation technology to cancel out the sound of snoring without disturbing the sleep of the snorer or their partner. In addition, SnoreFree is a startup that has developed a nasal dilator device that helps improve nasal airflow and reduce snoring. The device is designed to be comfortable and discreet, and it can be reused for up to 30 days. Restraints: Anti-snoring devices are considered medical devices and are subject to strict regulatory oversight by the FDA in the United States. This can make it difficult and expensive for companies to bring new products to market. Furthermore, many people who suffer from snoring are not aware of the various anti-snoring devices available to them. This can limit the demand for these devices and slow the growth of the market. Moreover, some anti-snoring devices, such as oral appliances, can cause discomfort, pain, and other side effects. This can make it difficult for some people to use the devices regularly. Developments: • ResMed is a leading player in the sleep apnea and snoring treatment market. In 2021, the company launched its AirSense 11 AutoSet CPAP device, which offers advanced therapy and real-time monitoring for sleep apnea patients. The device also has built-in cellular connectivity for remote monitoring and management. • Philips Respironics is a major manufacturer of sleep apnea and snoring treatment devices. In 2021, the company introduced its DreamWear Full Face CPAP mask, which is designed to provide a comfortable and effective solution for patients who breathe through their mouths during sleep. • ZQuiet is a company that specializes in anti-snoring devices. In 2021, the company introduced its new ZQuiet Nano device, which uses advanced technology to provide a comfortable and effective solution for snoring. • SnoreRx is a leading manufacturer of MADs for snoring treatment. In 2021, the company launched its new SnoreRx Plus device, which features improved adjustability and comfort for a more personalized fit. • SomnoMed is a global leader in the development and manufacture of oral appliances for sleep apnea and snoring treatment. In 2021, the company launched its new SomnoDent Fusion device, which features a customizable design for a comfortable and effective fit. Companies Mentioned in this Report: Koninklijke Philips N.V., LivaNova PLC, Fisher & Paykel Healthcare Corporation Limited., SomnoMed Inc, Medtronic plc, ResMed Inc., Airway Management Inc., PureSleep Company Inc. , GlaxoSmithKline plc, ZQuiet LLC, Rhinomed Limited, Mpowrx, Whole You, Inc., Rotech Healthcare Inc, Prosomnus Sleep Technologies, Zyppah Inc. Considered in this report • Geography: North America • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report • North Anti Snoring Device market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Countries covered in the report: • United States • Canada • Mexico By Product Type: • Mandibular Advancement Device • Nasal Device • Position Control Device • Chin Straps • EPAP/CPAP • Tongue Stabilizing By Distribution Chanel: • Hospitals • Clinics • Retail Pharmacies • E-commerce • Others The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, government-generated reports, and databases. After gathering the data from secondary sources, primary research was conducted by making telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started doing primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations and organizations related to the Anti Snoring Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services